Please use this identifier to cite or link to this item: https://gnanaganga.inflibnet.ac.in:8443/jspui/handle/123456789/692
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSingh, Satyendra Pratap-
dc.date.accessioned2023-05-22T06:16:03Z-
dc.date.available2023-05-22T06:16:03Z-
dc.date.issued2022-03-15-
dc.identifier.issn2582-3930-
dc.identifier.urihttp://gnanaganga.inflibnet.ac.in:8080/jspui/handle/123456789/692-
dc.description.abstractThere was a severe impact of outbreak of the pandemic of corona virus (COVID-19) on stock markets across the globe and Indian stock markets are no exception to this. With the outbreak of Covid, stock market indices fell sharply leading to drastic reduction in market capitalization of the listed companies. Though this trend has been reversed after rapid vaccination and some control over the pandemic. This study is an attempt to analyze the risk and return of prominent stocks in Pre-Covid and During Covid period. The researchers have analysed prominent stocks of FMCG, IT and Pharmaceutical sectors in India in terms of their risk and return on comparative basis in pre-covid and during covid time periods. The study reveals that FMCG sector offered the highest return in pre Covid period and IT Sector offered highest return in during Covid period. In terms of risk, Pharma sector had highest risk in pre-covid, and IT sector had highest risk in during Covid period. The study also shows that there is a significant different in the return and risk of most of the stocks in pre-covid and during covid periods.en_US
dc.language.isoenen_US
dc.publisherJSREMen_US
dc.subjectNifty50en_US
dc.subjectBetaen_US
dc.subjectCovid-19en_US
dc.subjectRisk, Returnen_US
dc.titleStudy on Risk and Return Analysis of Prominent Stocks of FMCG, IT and Pharmaceutical Sectorsin Pre-Covid and During Covid Perioden_US
dc.typeArticleen_US
Appears in Collections:Journal Articles



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.